Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.649 USD | +3.02% | +3.02% | +10.47% |
May. 15 | VBI Vaccines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Earnings Flash (VBIV) VBI VACCINES Reports Q1 Revenue $1.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.47% | 18.61M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- VBIV Stock
- News VBI Vaccines Inc.
- VBI Vaccines Sells Rights to Hepatitis B Vaccine to Brii Biosciences